Generation of safe and efficient, off-the-shelf, chimeric antigen receptor (CAR)-engineered T cells for broad application

Kenneth C Anderson

Molecular Sequelae of Myeloma-Bone Marrow Interactions: Therapeutic Applications

Multiple myeloma and immunoproliferative diseases

Hematology and hematologic malignancies Pathology

Jonathan Hofmann

Pooled Investigation of Circulating Adiponectin and Multiple Myeloma and Immunoproliferative Diseases in the NCI Cohort Consortium

Multiple myeloma and immunoproliferative diseases

Hematology and hematologic malignancies Pathology

Anneclaire J De Roos

Occupational Pesticide Use and Risk of Lymphoid Cancers

Non-Hodgkin lymphoma Multiple myeloma and immunoproliferative diseases Leukaemia

Linda J Burns

Training and Mentorship of Hematologic Oncologists

Non-Hodgkin lymphoma Multiple myeloma and immunoproliferative diseases Leukaemia Hodgkin lymphoma

Hematology and hematologic malignancies

Irene M. Ghobrial

Stroma-mediated clonal evolution in Multiple Myeloma

Multiple myeloma and immunoproliferative diseases

Tracy L Mcgaha

The role of marginal zone macrophages and immuno-metabolism in tumor-driven MDSC development

Non-Hodgkin lymphoma Multiple myeloma and immunoproliferative diseases Hodgkin lymphoma

Hematology and hematologic malignancies Pathology

Nathaniel Rothman

DDT, PCBs, and Other Persistent Organohalide Chemicals in the JANUS Cohort

Trachea, bronchus and lung Thyroid Testis Prostate Pancreas Ovary Non-Hodgkin lymphoma Multiple myeloma and immunoproliferative diseases Lip, oral cavity Leukaemia

Hematology and hematologic malignancies Pathology

Robert Zygmunt Orlowski

Role of TJP1 in Sensitivity and Resistance to Proteasome Inhibitors in Myeloma

Multiple myeloma and immunoproliferative diseases

Frederick Locke

Breaking immune tolerance to surviving in Multiple Myeloma

Multiple myeloma and immunoproliferative diseases